Accel-KKR, Carlyle, Vistria target home care software; Bain Capital, Bristol Myers Squibb launch autoimmune biopharma biz

Rounding up five deals in the home healthcare sector, which has caught the attention of Accel-KKR, Berkshire Partners, Carlyle, Vistria and other PE firms; a look at the launch of Bain Capital’s and Bristol Myers Squibb’s new autoimmune biopharma company; insights into the commercialization and market access to the services side of the pharma sector from a report by the investment bank Bourne Partners.

HealthcareCommentaryPE Hub Wire